225 related articles for article (PubMed ID: 37732588)
1. Lipid-Centric Design of Plasma Membrane-Mimicking Nanocarriers for Targeted Chemotherapeutic Delivery.
Ning D; Wang ZG; Wang L; Tian YF; Jing F; Jiang LH; Zhang MQ; Liu YY; Pang DW; Cho W; Liu SL
Adv Mater; 2024 Jan; 36(2):e2306808. PubMed ID: 37732588
[TBL] [Abstract][Full Text] [Related]
2. Nanocarriers surface engineered with cell membranes for cancer targeted chemotherapy.
Lei W; Yang C; Wu Y; Ru G; He X; Tong X; Wang S
J Nanobiotechnology; 2022 Jan; 20(1):45. PubMed ID: 35062958
[TBL] [Abstract][Full Text] [Related]
3. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
Koning GA; Krijger GC
Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
[TBL] [Abstract][Full Text] [Related]
4. Construction of Biomimetic-Responsive Nanocarriers and their Applications in Tumor Targeting.
Tian X; Shi A; Wu J
Anticancer Agents Med Chem; 2022; 22(12):2255-2273. PubMed ID: 34994336
[TBL] [Abstract][Full Text] [Related]
5. Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks.
Zhang RX; Ahmed T; Li LY; Li J; Abbasi AZ; Wu XY
Nanoscale; 2017 Jan; 9(4):1334-1355. PubMed ID: 27973629
[TBL] [Abstract][Full Text] [Related]
6. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles.
Li A; Zhao Y; Li Y; Jiang L; Gu Y; Liu J
Drug Deliv; 2021 Dec; 28(1):1237-1255. PubMed ID: 34142930
[TBL] [Abstract][Full Text] [Related]
7. Erythrocyte membrane bioinspired near-infrared persistent luminescence nanocarriers for in vivo long-circulating bioimaging and drug delivery.
Liu JM; Zhang DD; Fang GZ; Wang S
Biomaterials; 2018 May; 165():39-47. PubMed ID: 29501968
[TBL] [Abstract][Full Text] [Related]
8. Advancement of Lipid-Based Nanocarriers and Combination Application with Physical Penetration Technique.
Yang M; Gu Y; Tang X; Wang T; Liu J
Curr Drug Deliv; 2019; 16(4):312-324. PubMed ID: 30657039
[TBL] [Abstract][Full Text] [Related]
9. Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors.
Wang C; Guan W; Peng J; Chen Y; Xu G; Dou H
Acta Biomater; 2020 Feb; 103():247-258. PubMed ID: 31846802
[TBL] [Abstract][Full Text] [Related]
10. Fusogenic Cell-Derived nanocarriers for cytosolic delivery of cargo inside living cells.
Soprano E; Migliavacca M; López-Ferreiro M; Pelaz B; Polo E; Del Pino P
J Colloid Interface Sci; 2023 Oct; 648():488-496. PubMed ID: 37302232
[TBL] [Abstract][Full Text] [Related]
11. Catanionic Hybrid Lipid Nanovesicles for Improved Bioavailability and Efficacy of Chemotherapeutic Drugs.
Xie X; He D; Wu Y; Wang T; Zhong C; Zhang J
Methods Mol Biol; 2021; 2211():57-68. PubMed ID: 33336270
[TBL] [Abstract][Full Text] [Related]
12. Surface Functionalization of Polymeric Nanoparticles with Umbilical Cord-Derived Mesenchymal Stem Cell Membrane for Tumor-Targeted Therapy.
Yang N; Ding Y; Zhang Y; Wang B; Zhao X; Cheng K; Huang Y; Taleb M; Zhao J; Dong WF; Zhang L; Nie G
ACS Appl Mater Interfaces; 2018 Jul; 10(27):22963-22973. PubMed ID: 29905067
[TBL] [Abstract][Full Text] [Related]
13. What does the future hold for chemotherapy with the use of lipid-based nanocarriers?
Pucci C; Martinelli C; Ciofani G
Future Oncol; 2020 Feb; 16(5):81-84. PubMed ID: 31872773
[No Abstract] [Full Text] [Related]
14. Lipid nanocarriers: influence of lipids on product development and pharmacokinetics.
Pathak K; Keshri L; Shah M
Crit Rev Ther Drug Carrier Syst; 2011; 28(4):357-93. PubMed ID: 21967401
[TBL] [Abstract][Full Text] [Related]
15. Revolutionizing Neurocare: Biomimetic Nanodelivery Via Cell Membranes.
Liao J; Gong L; Xu Q; Wang J; Yang Y; Zhang S; Dong J; Lin K; Liang Z; Sun Y; Mu Y; Chen Z; Lu Y; Zhang Q; Lin Z
Adv Mater; 2024 Jun; 36(26):e2402445. PubMed ID: 38583077
[TBL] [Abstract][Full Text] [Related]
16. Lipid based nanocarriers: a translational perspective.
Mishra DK; Shandilya R; Mishra PK
Nanomedicine; 2018 Oct; 14(7):2023-2050. PubMed ID: 29944981
[TBL] [Abstract][Full Text] [Related]
17. Cell membrane-coated nanosized active targeted drug delivery systems homing to tumor cells: A review.
He Z; Zhang Y; Feng N
Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110298. PubMed ID: 31753336
[TBL] [Abstract][Full Text] [Related]
18. Biomimetic cell membrane-coated nanocarriers for targeted siRNA delivery in cancer therapy.
Huang X; Guo H; Wang L; Zhang Z; Zhang W
Drug Discov Today; 2023 Apr; 28(4):103514. PubMed ID: 36736580
[TBL] [Abstract][Full Text] [Related]
19. Cell membrane-camouflaged nanoparticles for drug delivery.
Luk BT; Zhang L
J Control Release; 2015 Dec; 220(Pt B):600-7. PubMed ID: 26210440
[TBL] [Abstract][Full Text] [Related]
20. Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.
Sala M; Diab R; Elaissari A; Fessi H
Int J Pharm; 2018 Jan; 535(1-2):1-17. PubMed ID: 29111097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
